• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Chondroplasty Companies

    ID: MRFR/Pharma/2861-HCR
    80 Pages
    Kinjoll Dey
    October 2025

    Chondroplasty is a surgical procedure involving the repair or reshaping of damaged cartilage, typically in the joints. Companies involved in the development and manufacturing of products related to chondroplasty may provide a range of solutions, including surgical instruments, implants, and technologies aimed at addressing cartilage-related issues. 

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Chondroplasty Market

    Chondroplasty Key Companies

     

    Latest Chondroplasty Companies Update


    Arthrex® Carticel® Autologous Chondrocyte Implant System In September 2023, Arthrex received FDA approval for its Carticel® Autologous Chondrocyte Implant System, an improved version of its existing cartilage repair technology. This system features optimized cell expansion and implantation techniques, potentially leading to better clinical outcomes.


    Conventus Orthopaedics' Magellan Autologous Chondrocyte Implant System launched its Magellan Autologous Chondrocyte Implant System in Europe in June 2023. This system offers a cost-effective and user-friendly approach to cartilage repair, potentially widening access to this treatment option.


    List of Chondroplasty Key Companies in the Market



    • Braun Melsungen AG

    • NuOrtho Surgical Inc.

    • Zimmer Biomet Holdings Inc.

    • Smith & Nephew plc

    • Nebula Inc.

    • Gpcmedical

    • Osiris Therapeutics Inc.

    • Sklar Surgical Instruments

    • Stryker Corporation